Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma

Chihwan Choi, Jinsil Seong

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background/Aims: Spinal metastases often severely limit the quality of life by causing severe pain and neurological deficits. The purpose of this study was to evaluate the palliative effect of radiotherapy (RT) for spinal metastases from hepatocellular carcinoma (HCC) and to identify factors predictive of survival in HCC patients with spinal metastases who received RT. Methods: A retrospective analysis was performed on 192 patients with spinal metastases from HCC who received RT. Results: Of 192 patients with spinal metastases from HCC, an overall pain response to palliative RT occurred in 187 patients (97.4%), with a complete pain response (CR) in 41 patients (21.4%) and a partial response in 151 patients (78.6%). A higher biologically effective dose (BED) and more advanced RT techniques were identified as predictive factors for a CR. The 1- and 2-year overall survival (OS) rates were 18.1% and 6.3%, respectively, and the median survival time was 4.5 months. A long OS was associated with good performance status, controlled primary HCC, absence of extrahepatic metastases, and a higher BED. Conclusions: RT provided effective palliation for patients with painful spinal metastases from HCC. Our results provide information regarding pain control, survival outcomes, and predictive factors for the prognosis of HCC patients with spinal metastases treated with RT.

Original languageEnglish
Pages (from-to)94-102
Number of pages9
JournalGut and Liver
Volume9
Issue number1
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Hepatocellular Carcinoma
Radiotherapy
Neoplasm Metastasis
Survival
Pain
Survival Rate
Quality of Life

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

@article{61ad580527a84145814a32865598f878,
title = "Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma",
abstract = "Background/Aims: Spinal metastases often severely limit the quality of life by causing severe pain and neurological deficits. The purpose of this study was to evaluate the palliative effect of radiotherapy (RT) for spinal metastases from hepatocellular carcinoma (HCC) and to identify factors predictive of survival in HCC patients with spinal metastases who received RT. Methods: A retrospective analysis was performed on 192 patients with spinal metastases from HCC who received RT. Results: Of 192 patients with spinal metastases from HCC, an overall pain response to palliative RT occurred in 187 patients (97.4{\%}), with a complete pain response (CR) in 41 patients (21.4{\%}) and a partial response in 151 patients (78.6{\%}). A higher biologically effective dose (BED) and more advanced RT techniques were identified as predictive factors for a CR. The 1- and 2-year overall survival (OS) rates were 18.1{\%} and 6.3{\%}, respectively, and the median survival time was 4.5 months. A long OS was associated with good performance status, controlled primary HCC, absence of extrahepatic metastases, and a higher BED. Conclusions: RT provided effective palliation for patients with painful spinal metastases from HCC. Our results provide information regarding pain control, survival outcomes, and predictive factors for the prognosis of HCC patients with spinal metastases treated with RT.",
author = "Chihwan Choi and Jinsil Seong",
year = "2015",
month = "1",
day = "1",
doi = "10.5009/gnl14009",
language = "English",
volume = "9",
pages = "94--102",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "1",

}

Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma. / Choi, Chihwan; Seong, Jinsil.

In: Gut and Liver, Vol. 9, No. 1, 01.01.2015, p. 94-102.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma

AU - Choi, Chihwan

AU - Seong, Jinsil

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background/Aims: Spinal metastases often severely limit the quality of life by causing severe pain and neurological deficits. The purpose of this study was to evaluate the palliative effect of radiotherapy (RT) for spinal metastases from hepatocellular carcinoma (HCC) and to identify factors predictive of survival in HCC patients with spinal metastases who received RT. Methods: A retrospective analysis was performed on 192 patients with spinal metastases from HCC who received RT. Results: Of 192 patients with spinal metastases from HCC, an overall pain response to palliative RT occurred in 187 patients (97.4%), with a complete pain response (CR) in 41 patients (21.4%) and a partial response in 151 patients (78.6%). A higher biologically effective dose (BED) and more advanced RT techniques were identified as predictive factors for a CR. The 1- and 2-year overall survival (OS) rates were 18.1% and 6.3%, respectively, and the median survival time was 4.5 months. A long OS was associated with good performance status, controlled primary HCC, absence of extrahepatic metastases, and a higher BED. Conclusions: RT provided effective palliation for patients with painful spinal metastases from HCC. Our results provide information regarding pain control, survival outcomes, and predictive factors for the prognosis of HCC patients with spinal metastases treated with RT.

AB - Background/Aims: Spinal metastases often severely limit the quality of life by causing severe pain and neurological deficits. The purpose of this study was to evaluate the palliative effect of radiotherapy (RT) for spinal metastases from hepatocellular carcinoma (HCC) and to identify factors predictive of survival in HCC patients with spinal metastases who received RT. Methods: A retrospective analysis was performed on 192 patients with spinal metastases from HCC who received RT. Results: Of 192 patients with spinal metastases from HCC, an overall pain response to palliative RT occurred in 187 patients (97.4%), with a complete pain response (CR) in 41 patients (21.4%) and a partial response in 151 patients (78.6%). A higher biologically effective dose (BED) and more advanced RT techniques were identified as predictive factors for a CR. The 1- and 2-year overall survival (OS) rates were 18.1% and 6.3%, respectively, and the median survival time was 4.5 months. A long OS was associated with good performance status, controlled primary HCC, absence of extrahepatic metastases, and a higher BED. Conclusions: RT provided effective palliation for patients with painful spinal metastases from HCC. Our results provide information regarding pain control, survival outcomes, and predictive factors for the prognosis of HCC patients with spinal metastases treated with RT.

UR - http://www.scopus.com/inward/record.url?scp=84919359644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919359644&partnerID=8YFLogxK

U2 - 10.5009/gnl14009

DO - 10.5009/gnl14009

M3 - Article

VL - 9

SP - 94

EP - 102

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 1

ER -